Product Name: Turanabol
Manufacturer: Balkan Pharmaceuticals
Presentation: Box with 25 tablets of 10mg
Active ingredient: Chlorodehydromethyltestosteronum

Active Life: Approx. 8-10 hours
Suggested Use: 20-50mg/zi
Acne: NO
Water retained: NO
High Voltage: NO
Liver Toxicity: Low
DHT Conversion: No
Flavouring: NO
Own inhibition test: Yes, dose and time dependent

Turanabol (4-chloro-1-dihydro-17-alpha-metiltestosteron) is considered an oral steroid for anabolic properties mainly by reducing the androgen.

Thus, it is considered that the androgenic activity is 6% and 53% anabolic. Compared with the action Turanabolul metandrostenolonul has androgenic and anabolic 45% to 90%.

Turanabolul metandrostenolonului is a derivative of that in position 4 has introduced a chlorine atom (4-chloro-1-dihydro-17 alpha methyl testosterone). This change kept available for internal administration but is subject to first pass metabolism. An important feature is the lack of preparation in the metabolic conversion into estrogen as flavoring, not supine.
Turanabolul pretty fast metabolism is subject to, and the metabolites are eliminated from the body relatively quickly (not already determined in urine over 6-8 days after suspension of administration).

   Is a potent derivative of Dianabol. But unlike it is much softer, with lower androgenic effects. Anabolic effect is somewhat lower than with Dianabol, but maintain a better balance between anabolic and androgenic effects, meaning that any accumulation of muscle mass gains proportionality to the side effects will be in favor turabolinului. It will be less likely to cause acne, oily skin, hair loss, aggressiveness, from Dianabol.

   Because no flavor, estrogenic effects such as gynecomastia, water retention, fat accumulation will not be a problem. While Dianabol may give the appearance of "soft body" and favors a certain accumulation of fat, if we say that the opposite happens Turanabolului. Tend to favor smooth muscle gain and highlight muscles. For bodybuilders that makes a steroid Turanabol preferred to competitions or when you wish to define.
   Turanabol adult dose is 20-50 mg per day. Length is considered adequate diet for 2-6 weeks.

Original product package:


Turanabol (4-chloro-1-dihydro-17-alpha-metiltestosteron) is considered an oral steroid for anabolic properties mainly by reducing the androgen.

Thus, it is considered that the androgenic activity is 6% and 53% anabolic. Compared with the action Turanabolul metandrostenolonul has androgenic and anabolic 45% to 90%.

Turanabolul as androgenic and anabolic steroids, penetrates cell membranes and interact with cytoplasmic receptors and the complex formed is transported to the nucleus where it acts on specific nuclear receptors. Active complex binds DNA and acts as a transcription factor that determines the synthesis of RNA and specific proteins.

Turanabolul manifested mostly anabolic effect that is particularly evident in striated muscle and bone and other tissues with intense division (bone marrow, mucous, etc..). Preparation first determines muscle growth and weight curve (lesser effect as testosterone, but can be enhanced when used with other anabolic).

Contribute to setting the bones of calcium in bones, possibly due to increased matrix protein formation and / or reduction of parathyroid hormone responsiveness to the bone. An essential role in achieving anabolic effect has the metabolic changes: a positive nitrogen balance (nitrogen retention), increased protein synthesis, decreasing catabolism of amino acids, phosphorus and potassium retention. The drug stimulates hematopoiesis, especially erythropoiesis (erythropoietin formation increases), and favors leucopoieza and platelet formation.

The pharmacokinetics

Turanabolul metandrostenolonului is a derivative of that in position 4 has introduced a chlorine atom (4-chloro-1-dihydro-17 alpha methyl testosterone). This change kept available for internal administration but is subject to first pass metabolism. An important feature is the lack of preparation in the metabolic conversion into estrogen as flavoring, not supine.
Turanabolul pretty fast metabolism is subject to, and the metabolites are eliminated from the body relatively quickly (not already determined in urine over 6-8 days after suspension of administration).

Indications

Protein synthesis disorders, cachexia of various genesis, trauma, extensive burns, infectious diseases and after irradiation, muscular dystrophy, osteoporosis, negative nitrogen balance corticosteroid therapy, aplastic anemia and hypo.

Turanabolul as prepared predominantly anabolic effect, may be indicated as adjunctive treatment in cases of protein catabolism with negative nitrogen balance (shortage, excessive consumption or loss of protein) in elderly with state of hunger and cachexia, the fatigue, cachexia different origin in large combustion and bedsores, after surgery, infection and major trauma, osteoporosis, use of glucocorticoids lasting, hypo-and aplastic anemia, hemolytic anemia chronic anemia of chronic renal failure, anemia caused by tumors, lymphomas and leukemia , idiopathic thrombocytopenia, muscle atrophy in patients with AIDS in the pediatric practice in case of increasing retention, anorexia (no appetite), weight reduction etc.

DOSAGE AND METHOD OF ADMINISTRATION

Anabolic steroids is adjunctive therapy and not a substitute for basic treatment. Duration of use is dependent Turanabolului patient's response and the development of possible side effects.
Adults: response to steroid anabolicele is varied. Turanabol adult dose is 20-50 mg per day. Length is considered adequate diet for 2-6 weeks.

SIDE EFFECTS

Liver: cholestatic jaundice, rarely hepatic necrosis with hepatocytes, hepatocellular neoplasms. You can change the biochemical parameters: increase in bilirubin, alkaline phosphatase, transaminases. Cholestatic jaundice may develop after six weeks or more of treatment (home is considered toxic) and is manifested by capillary biliary stasis with hyperbilirubinemia and increased alkaline phosphatase content. When using long years may increase the frequency of liver tumors.

Endocrine disorders: Turanabol less frequently than other anabolic in men can cause: reduced spermatogenesis and sexual potency (secondary decrease gonadotropin secretion and testosterone with testicular atrophy and oligospermia), prostatic hypertrophy (mainly in older patients), epididymitis, chronic priapism. The boys can cause early maturation, frequent erections, increased risk retention.

Cause women: inhibition of gonadotropin secretion, virilizing phenomena (acne, hirsutism, deepening voice, increased libido, menstrual disorders, clitoral hypertrophy, muscle development). In pregnant women may cause fetal virilization. Turanabol frequency of adverse effects is low.

Neurological disorders: excitation, insomnia, depression, confusion.
Metabolism: reduced glucose tolerance, increased levels lipoproteidelor low density lipoprotein (LDL), accelerate the elimination of creatinine level increase cretininfoafokinazei, swelling due natriului reabsorption and water retention, potassium, calcium, phosphorus. In people long attached to the bed can be found hypercalcemia.

Diverse during puberty may terminate early epiphyseal areas with increased retention.

CONTRAINDICATIONS

Hypersensitivity to the drug, cancer and enlarged prostate, breast cancer in men, breast carcinoma in women with hypercalcemia, ovarian, ICC, severe atherosclerosis, nephritis, nephrotic syndrome, hepatic and renal impairment, acute and chronic prostatitis, pregnancy, lactation , time to sexual maturation.
Overdose
Cases of overdose have been reported.

Warnings and precautions for use

When prescribing steroids anabolicelor patients should be informed about possible side effects with your doctor immediately addressing their occurrence. At the first signs of virilizing patients (deepening of the voice, hirsutism, acne, clitoromegalie) administration should be stopped to avoid irreversible changes.

Preparations of this group can cause suppression of plasma coagulation factors II, V, VII, X, which requires careful monitoring, including concomitant use with indirect anticoagulants.

During treatment it is necessary to monitor liver function parameters (transaminases, alkaline phosphatase, bilirubin) and lipid spectrum (cholesterol and low density lipoproteidelor). The elderly may find an increased incidence of hypertrophy and prostate carcinoma requiring close supervision.

In children anabolicelor steroid use precautions because they may accelerate epiphyseal closure, an effect that may last for 6 months after suspension. For these reasons it is recommended that consultation with specialists about drug use rationality to control radiological bone maturation.

Patients on high doses of anabolic steroids is necessary to determine hemoglobin and hematocrit regularly because of polycythemia possible.

Interaction with other medicinal

Glucocorticoids, mineralocorticoizii, corticotropin, preparations containing sodium and sodium-rich foods enhances the body fluid retention, increased risk of developing edema, acne eruptions intensified.

The concomitant use of anticoagulants and increase blood anabolicele indirect effects in which case the dose reduced. Monitoring is needed to decide on further treatment with anabolic or suspension. It is necessary to monitor the prothrombin time.

Turanabolul can alter the effects of oral antihipoglicemiantelor (possibly by inhibiting the metabolism hypoglycaemic hypoglycemia increases risk and by reducing glucose tolerance will increase blood sugar).

Concomitant use of ACTH and corticosteroids in patients with edema which may be increased, but the probability is very small. Anabolics steroids reduces the level of globulin coupled with the reduced level of total thyroxine T4 and T3 uptake and T4 growth. Free fraction of thyroid hormone levels remain unchanged. The ability to capture radioactive iodine is retained.